acedata-driven clinical subphenotyping of bloodstream infections to stratify mortality risk and guide therapy
Source article: Clinical phenotyping of bloodstream infections: a review of current evidence
Abstract: Bloodstream infections (BSIs) are a leading cause of morbidity and mortality, yet their clinical heterogeneity continues to challenge effective patient stratification and treatment optimisation. In other heterogeneous conditions such as sepsis, data-driven clinical subphenotyping has identified reproducible subgroups with distinct outcomes and treatment responses. Whether similar approaches can be applied to BSIs to improve clinical management and trial design is an area of growing interest. We aimed to review t…
Contested: both sides are scored from claims and sources, not community votes.
Positive BD Bactec blood culture vial expressing turbidity-Serratia marcescens by Ajay Kumar Chaurasiya. CC0 · http://creativecommons.org/publicdomain/zero/1.0/deed.en
By August 2026, a review in Clinical Microbiology and Infection summarized evidence on using unsupervised machine learning to derive clinical subphenotypes of bloodstream infections. The strongest data were in Staphylococcus aureus bacteraemia, where latent class and cluster analyses identified distinct subgroups with different mortality across cohorts, with emerging work in ICU mixed-pathogen and transplant populations and early bedside calculators for phenotype assignment.
The approach matters because bloodstream infections are a leading cause of morbidity and mortality with marked heterogeneity that complicates treatment and trial design. If validated, AI-derived phenotypes could improve risk stratification and enable personalized antimicrobial therapy and enriched trials, but current evidence is limited by inconsistent methods, sparse external validation, and lack of integration with biological endotypes and prospective interventional testing.
- Review focused on data-driven phenotyping and unsupervised machine learning for bloodstream infections.
- Most extensive evidence is in Staphylococcus aureus bacteraemia using latent class analysis and cluster analysis.
- Emerging evidence includes mixed-pathogen ICU cohorts and immunocompromised groups such as solid organ transplant recipients.
- Authors report development of bedside tools including online calculators and simplified scoring systems for rapid phenotype assignment.
Unsupervised machine learning applied to bloodstream infections identifies reproducible clinical subphenotypes with different mortality, supporting bedside tools for rapid phenotype assignment and personalized antimicrobial therapy.
Studies use inconsistent phenotyping methods and provide limited validation, slowing translation of AI-derived BSI subphenotypes into routine clinical practice.
The rundown
The review searched PubMed/MEDLINE and Semantic Scholar AI-assisted search tool and hand-searched references to collect studies using data-driven phenotyping for BSIs. Methods highlighted include latent class analysis and cluster analysis, most studied in Staphylococcus aureus bacteraemia across independent international cohorts.
Findings extend to mixed-pathogen BSI cohorts in the intensive care unit and immunocompromised populations including solid organ transplant recipients. The authors note bedside tools such as online calculators and simplified scoring systems have been developed, but validation data are limited and future work should include phenotype-stratified interventional trials.
Different studies use varying methodological approaches and validation remains limited, with underrepresented BSI aetiologies and lack of integration with biological endotypes.
Sources
- Peer-reviewedClinical Microbiology and Infection2026-08-26
How should this claim be treated?
The debate